tiprankstipranks
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Germany Market
4XC1
KalVista Pharmaceuticals
RESEARCH TOOLSreports

KalVista Pharmaceuticals (4XC1) Cash flow

0 Followers

KalVista Pharmaceuticals Cash Flow

DE:4XC1's free cash flow for Q3 2026 was $45.52M. For the 2026 fiscal year, DE:4XC1's free cash flow was decreased by $-63.67M and operating cash flow was $45.36M. See a summary of the company’s cash flow.
Cash Flow
Apr 25Apr 24Apr 23Apr 22Apr 21
Operating Cash Flow
$ -152.91M$ -89.23M$ -75.26M$ -78.13M$ -30.17M
Investing Cash Flow
$ 91.02M$ -84.72M$ 41.41M$ 57.86M$ -147.65M
Financing Cash Flow
$ 159.73M$ 150.71M$ 58.12M$ 1.58M$ 212.12M
End Cash Position
$ 131.62M$ 31.79M$ 56.24M$ 30.73M$ 50.59M
Free Cash Flow
$ -153.34M$ -89.67M$ -76.46M$ -79.06M$ -30.25M
Currency in USD

KalVista Pharmaceuticals Cash Flow